Validation of the Lung Immune Prognostic Index in patients with untreated advanced non-small cell lung cancer: Post hoc analysis of the IMpower 130, 131 and 150 trials

Lung, Respiratory and Thoracic Cancer
Do you want to read an article? Please log in or register.